Iran Hormone

Iran Hormone Pharmaceutical Company is a leading Iranian pharmaceutical manufacturer specializing in the production of hormonal and steroidal medications. Founded in 1962 as a joint venture with Schering AG, the company has established itself as a critical supplier of endocrine, gynecological, and oncology treatments in the Middle East. Its extensive product portfolio includes a wide range of oral and injectable formulations, such as prednisolone, levothyroxine, and various sex hormones. The company operates advanced manufacturing facilities that adhere to international GMP standards and is a key subsidiary of the Tamin Pharmaceutical Investment Company (TPICO). Iran Hormone is publicly listed on the Tehran Stock Exchange and continues to play a vital role in the regional healthcare infrastructure.